Current Opinion in Ophthalmology · 2006 · 45 citations · 11 references
MedicineEndocrinologyOncologyBreast OncologyMetastasisOcular OncologyBreast Cancer OncologyBreast Cancer SurgeryBreast SurgeryHormonal Cancer TherapyHormonal TherapyMetastatic Breast CancerAromatase InhibitionAromatase InhibitorsHormone Receptor - Positive Breast CancerHormone Receptor-positive Breast Cancer TherapyPostmenopausal Hormone TherapyUveal MetastasesUveal Tumors
PURPOSE OF REVIEW: The outcome of patients diagnosed with uveal metastases from breast carcinoma, all of whom were treated with one of the new generation of hormone therapies named aromatase inhibitors, is reported. RECENT FINDINGS: Charts of all patients with uveal metastases from breast cancer seen at Wills Eye Hospital between 1995 and 2005 are reviewed. Seventeen patients were diagnosed with uveal metastases from estrogen-receptor-positive breast cancer and subsequently treated with one of the aromatase inhibitors (anastrozole, letrozole, exemestane). SUMMARY: The interval between initial diagnosis of breast cancer and choroidal metastases ranged from 1 month to 17 years. Thirteen patients had received tamoxifen either at the time of breast surgery or as part of the metastases treatment. In 10 cases, both the systemic and choroidal metastases remained regressed over a mean of 20 months follow-up (4-50 months). There was no toxicity or intolerance to the medication. Aromatase inhibitors represent a new generation of hormone therapy for metastatic breast cancer. They were effective in 59% of the patients with estrogen-receptor-positive breast cancer, many of them nonresponding to prior treatment with tamoxifen. Aromatase inhibitors avoid the need for external beam radiation therapy as a treatment for the ocular metastases.
11
M Baum, Aman U. Budzar, J Cuzick et al. · The Lancet · 2002 · 2K citations
Pharmacy, Oncology, Pharmacotherapy +13
Henning T. Mouridsen, Mikhail Gershanovich, Yan Sun et al. · Journal of Clinical Oncology · 2001 · 1K citations · Full text
Medicine, Oncology, Pharmacology +17
Survey of 520 Eyes with Uveal Metastases
Carol L. Shields, Jerry A. Shields, Geoffrey P. Schwartz et al. · Ophthalmology · 1997 · 1K citations
Medicine, Oncology, Ophthalmology +12
Uveal metastasis from breast cancer in 264 patients
Hakan Demirci, Carol L. Shields, An‐Ning Chao et al. · American Journal of Ophthalmology · 2003 · 268 citations
Medicine, Oncology, Ophthalmology +14